Codexis Bio (CDXS) - Earnings per share increase in current year

Official company branding of Codexis (CDXS)

Is it worth investing in Codexis, Inc. (CDXS), given that its cycle remains independent of global crises? The annual earnings per share trajectory confirms the business's resilience, as the integration of enzymes into medical production minimizes seasonality. Today 24.80 expresses the value of the metric today. Its leadership status in protein engineering and patent protection provide Codexis, Inc. (CDXS) with significant pricing power.

CDXS Codexis, Inc. Earnings per share growth in current year (07/04/2022 - 11/10/2026)

Comprehensive metric breakdowns and analytics for codexis.com (CDXS)

- current quotes and average value forecast:
Market Chart Codexis|CDXS - Consensus Target
- market capitalization indicators:
Market Value CDXS|CDXS - Enterprise Value
- business book valuation details:
Net Assets per Share Codexis, Inc.|CDXS - Company Book Value|Capitalization to Book Value Ratio codexis.com|CDXS - Company Total Assets
- debt burden and liquidity indicators:
Total Debt to Equity Ratio Codexis, Inc.|CDXS - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Coefficient Codexis|CDXS - Company Aggregate Debts|Debt to Book Value CDXS|CDXS - Company Long-Term Debts|Company Short-Term Indebtedness Codexis, Inc.|Immediate Liquidity Ratio codexis.com
- earnings and multiples data:
CDXS - Company Net Income|Company Profit Forecast Codexis, Inc.|CDXS - P/E Multiple|Price to Future Earnings Ratio Codexis|CDXS - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation CDXS|CDXS - Operating profit EBITDA|Net earnings per share (EPS TTM) Codexis, Inc.|CDXS - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months codexis.com|CDXS - Earnings per share growth in current year|Expected net earnings per share growth next year Codexis, Inc.
Fundamental valuation:CDXS, Codexis Bio
Core merchandise of Codexis Bio

This annual earnings per share growth rate reflects the monetization efficiency of Codexis, Inc. (CDXS) unique AI developments in biocatalysis and enzyme synthesis. The metric is calculated as the percentage deviation of current earnings per share from the same value last year, allowing investors to filter out market noise and assess the real dynamics of the fundamental business while avoiding overpaying for the issuer's past successes.

Direct competitors

TEM - Expected net earnings per share growth this year|Net earnings per share growth this year QGEN|IONS: Earnings per share increase in current year|Earnings growth in current year RGEN|Expected net earnings per share growth this year aviditybiosciences.com|Earnings per share growth in current year CRISPR Therapeutics CRSP|WGS: Earnings per share growth this year|Ultragenyx Pharma - Earnings growth in current year|Beam Tx (BEAM) - Net earnings per share growth this year|SRPT (Sarepta Therapeutics, Inc.) - Net earnings per share growth this year|TWST - Expected net earnings per share growth this year|TXG (10x Genomics) - Earnings growth in current year|Net earnings per share growth this year Intellia Therapeutics Inc (NTLA)|Earnings growth in current year STOK|BioLife - Earnings per share growth this year|Wave Life Sciences - Net earnings per share growth this year|MAZE: Earnings per share growth this year|SION - Earnings per share growth in current year|Expected net earnings per share growth this year Prime Medicine Inc PRME|TSHA: Earnings growth in current year|Earnings per share growth this year QURE|Earnings per share growth in current year MeiraGTx Holdings plc|Earnings per share growth this year RGNX (regenxbio.com)|Earnings growth in current year SLDB|Earnings growth in current year Ocugen Inc (OCGN)|Earnings growth in current year PACB (Pacific Biosciences of California)|BNTC - Net earnings per share growth this year|DSGN - Earnings per share growth in current year|Earnings per share growth rate in current year rocketpharma.com|FDMT: Earnings growth in current year|Earnings per share growth this year LXEO|KRRO (Korro Bio Inc.) - Earnings growth in current year|Earnings per share growth rate in current year Editas Corp EDIT|Net earnings per share growth this year SLN (Silence Therapeutics)|proqr.com - Earnings per share growth this year|Earnings growth in current year SGMO (Sangamo Therapeutics, Inc.)|Expected net earnings per share growth this year Nautilus Biotechnology, Inc. (NAUT)|MGX - Earnings per share growth in current year|Expected net earnings per share growth this year precisionbiosciences.com DTIL|GBIO (generationbio.com) - Net earnings per share growth this year|boundlessbio.com - Earnings per share increase in current year|XCUR (Exicure Inc.) - Earnings growth in current year|Celsion Corporation (IMNN) - Expected net earnings per share growth this year|Earnings per share growth in current year Phio Pharmaceuticals (PHIO)|mustangbio.com - Earnings per share growth this year|Earnings growth in current year RNAZ (TransCode Therapeutics, Inc.)|BNGO - Net earnings per share growth this year|APDN: Net earnings per share growth this year|Expected net earnings per share growth this year bluebird bio Inc. BLUE|IPA: Earnings growth in current year|Net earnings per share growth this year Omega Therapeutics Corp|OMIC (Singular Genomics Systems) - Earnings growth in current year|Earnings per share growth this year RGLS (regulusrx.com)|Net earnings per share growth this year SYRS (Syros Pharmaceuticals, Inc.)|Telesis Bio Inc. - Earnings per share growth this year|Earnings per share growth in current year TRACON TCON|Expected net earnings per share growth this year Unity Biotechnology, Inc (UBX)